<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Status of various policies and interventions to contain viral hepatitis in the Asia-Pacific region</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th align="left">
     <bold>India</bold>
    </th>
    <th align="left">
     <bold>Pakistan</bold>
    </th>
    <th align="left">
     <bold>Bangladesh</bold>
    </th>
    <th align="left">
     <bold>China</bold>
    </th>
    <th align="left">
     <bold>Japan</bold>
    </th>
    <th align="left">
     <bold>South Korea</bold>
    </th>
    <th align="left">
     <bold>Indonesia</bold>
    </th>
    <th align="left">
     <bold>Taiwan</bold>
    </th>
    <th align="left">
     <bold>Singapore</bold>
    </th>
    <th align="left">
     <bold>Australia and New Zealand</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">National plan</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">In drafting stage</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Reliable national epidemiological data</td>
    <td align="left">No</td>
    <td align="left">Yes (national)</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Reliable economic burden data</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Mandatory screening for HBV and HCV of donated blood</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Mandatory nucleic-acid testing for screened blood</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes (12 tertiary care centres for blood screening in surrounding areas)</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Safe injections policy implementation</td>
    <td align="left">Yes (not well applied)</td>
    <td align="left">No</td>
    <td align="left">Yes (not well applied)</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes (institution level since 2015 after hepatitis C outbreak)</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Needle exchange and opioid substitution programmes for intravenous drug users</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">No (zero-tolerance policy on drugs)</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Children with 3 doses of hepatitis B vaccine (%, year)</td>
    <td align="left">63·0%, 2015–16</td>
    <td align="left">54·0% (by the age of 12–23 months), 2015</td>
    <td align="left">97·0%, 2016</td>
    <td align="left">99·0%, 2016</td>
    <td align="left">99·0%, 2016</td>
    <td align="left">99·0%, 2016</td>
    <td align="left">93·3%, 2016</td>
    <td align="left">97·9%, 2017</td>
    <td align="left">96·1%, 2016</td>
    <td align="left">100% (children born after May 1, 2000), 2016</td>
   </tr>
   <tr>
    <td align="left">Birth dose HBV vaccine coverage (%)</td>
    <td align="left">45·0%, 2015</td>
    <td align="left">No (pentavalent vaccine given at 6, 10, and 14 weeks of age)</td>
    <td align="left">No</td>
    <td align="left">90·0%, 2016</td>
    <td align="left">99·0%, 2016</td>
    <td align="left">99·0%, 2016</td>
    <td align="left">32·4%, 2016</td>
    <td align="left">98·7%, 2016</td>
    <td align="left">100% (assumed, no data available)</td>
    <td align="left">&gt;95 ·0% (children born to mothers with hepatitis B receive vaccine and hyperimmune globulin within first 24 h after delivery and complete doses thereafter), 2016</td>
   </tr>
   <tr>
    <td align="left">HBV vaccination for health-care workers</td>
    <td align="left">Yes</td>
    <td align="left">Yes (80% coverage)</td>
    <td align="left">Piloting stage</td>
    <td align="left">Partially</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Publicly funded HBV and HCV screening programmes</td>
    <td align="left">In a few states</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes for HBV; for HCV only (abnormal ALT &gt;60 IU/mL)</td>
    <td align="left">Started in a few areas, will be expanded to the whole country</td>
    <td align="left">Yes for narrow age ranges (≥18 years 
     <italic>vs</italic> ≤years)
    </td>
    <td align="left">Yes (National Childhood Immunisation Programme)</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">HBV screening for pregnant women</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">To be implemented</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">HBV medicines on national essential medicines list or subsidised by the Government</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Partially</td>
    <td align="left">No</td>
    <td align="left">70% subsidised by national insurance reimbursement policy</td>
    <td align="left">Provided via Government-owned insurance</td>
    <td align="left">Yes</td>
    <td align="left">Yes (entecavir and tenofovir)</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">HCV medicines on national essential medicines list or subsidised by the Government</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Free direct-acting antiviral drugs in piloting stage</td>
    <td align="left">Partially</td>
    <td align="left">No</td>
    <td align="left">70% subsidised by national insurance reimbursement policy</td>
    <td align="left">In application to Indonesian FDA</td>
    <td align="left">Yes</td>
    <td align="left">Yes (pegylated interferon and ribavirin)</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Households with an improved drinking water source (%, year)</td>
    <td align="left">89·9%, 2015–16</td>
    <td align="left">93·0%, 2012–13</td>
    <td align="left">98·0%, 2017</td>
    <td align="left">95·5%, 2015</td>
    <td align="left">97·0%, 2016</td>
    <td align="left">&gt;90·0% (water purification controlled by Waterworks Bureau except rural areas), 2015</td>
    <td align="left">45·5%, 2007</td>
    <td align="left">93·4%, 2015</td>
    <td align="left">100%, 2016</td>
    <td align="left">100%, 2016</td>
   </tr>
   <tr>
    <td align="left">Households using improved sanitation facility (%, year)</td>
    <td align="left">48·4%, 2015–16</td>
    <td align="left">59·5%, 2012–2013 (unshared facility); 9·6% (shared facility)</td>
    <td align="left">75·0% (2017)</td>
    <td align="left">76·5%, 2015</td>
    <td align="left">99·7%, 2016</td>
    <td align="left">&gt;90·0%, 2015</td>
    <td align="left">..</td>
    <td align="left">100%, 2015</td>
    <td align="left">100%, 2016</td>
    <td align="left">100%, 2016</td>
   </tr>
   <tr>
    <td align="left">National sanitation and cleanliness programme</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">No</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
    <td align="left">Yes</td>
   </tr>
   <tr>
    <td align="left">Status of HAV vaccination</td>
    <td align="left">Not in a national programme (currently not needed)</td>
    <td align="left">Not in a national programme</td>
    <td align="left">Not in a national programme</td>
    <td align="left">Yes</td>
    <td align="left">Not in a national programme</td>
    <td align="left">Yes</td>
    <td align="left">Not in a national programme</td>
    <td align="left">Yes (for all neonates, 70·9% born in 2012–16 received 2 doses)</td>
    <td align="left">Not in a national programme</td>
    <td align="left">Recommended for particular high-risk groups</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>ALT=alanine aminotransferase.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
